Antibiotice S.A. (BVB:ATB)

Market Cap	1.64B
Revenue (ttm)	648.96M
Net Income (ttm)	56.90M
Shares Out	671.34M
EPS (ttm)	0.08
PE Ratio	28.79
Forward PE	n/a
Dividend	0.02 (0.84%)
Ex-Dividend Date	Sep 25, 2025

Volume	221,022
Average Volume	170,793
Open	2.420
Previous Close	2.440
Day's Range	2.410 - 2.460
52-Week Range	1.750 - 2.725
Beta	0.23
RSI	51.73
Earnings Date	Nov 20, 2025

About Antibiotice

Antibiotice S.A. produces and sells medicinal products in Romania and internationally. The company offers generic prescription medicines comprising anti-infectives, including drugs for the treatment of tuberculosis, as well as cardiovascular drugs, digestive tract and metabolism class, preparations for the treatment of gynecological diseases, and dermatological and central nervous system preparations; generic non-prescription medicines, including food supplements, cosmetics, and medical devices; active substances; biofertilizers; biocides for d...

• Industry: Pharmaceutical Preparations
• Founded: 1955
• Employees: 1,357
• Stock Exchange: Bucharest Stock Exchange
• Ticker Symbol: ATB

Financial Performance

In 2024, Antibiotice's revenue was 688.70 million, an increase of 11.93% compared to the previous year's 615.29 million. Earnings were 102.20 million, an increase of 26.04%.